WINNIPEG, Manitoba, April 25, 2023 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has entered into an agreement with Yukon Liquor Corporation (“YLC”) to supply recreational use cannabis products to YLC for sale in Yukon Territory.
“This marks our seventh Canadian provincial and territorial supply agreement after Manitoba, Saskatchewan, Alberta, British Columbia, Ontario, and Newfoundland and Labrador,” said John Arbuthnot, CEO of Delta 9. “We continue to expand our market access domestically and look forward to supplying retail stores and consumers in the Yukon with Delta 9’s premium branded cannabis products.”
The Company plans to make its first shipment of cannabis for retail sale in the Yukon in the second quarter of 2023. Delta 9 is in continued discussions with other provinces, territories and private retail outlets and plans to secure additional cannabis supply agreements over the balance of 2023.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
Mobile: 204-898-7722
E-mail: ian.chadsey@delta9.ca
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the Toronto Stock Exchange under the symbol “DN” and on the OTCQX under the symbol “DLTNF”. For more information, please visit www.invest.delta9.ca.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward-looking statements in this news release include statements relating to the Company’s intent to supply products to YLC. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including all risk factors set forth in the annual information form of Delta 9 dated March 31, 2023 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
![](https://ml.globenewswire.com/media/NDRhNWQxMzAtZDI2MC00ZjVjLThjODEtOGFmZTA5Njk5MjI0LTExOTAzODg=/tiny/Delta-9-Cannabis.png)